Barbara Ann Karmanos Cancer Institute
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects
This study focuses on testing the effectiveness of MyPatientPal+, the combination of MyPatientPal smartphone app and a newly developed provider dashboard, on patient quality of life, adherence to medications, and severity of side effects on patients who are on cancer treatment. Participants will use the MyPatientPal+ smartphone daily to complete daily patient reported outcome questions (PROs) for 8 weeks. Providers will enter information as desired and not on a set schedule.
Inclusion Criteria: Patients- * 18-70 Years of age * have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer * about to initiate chemotherapy using one of the regimens listed in the protocol * be able to speak, read, and write English * willing and able to provide consent * have access to a stable internet connection Providers: * being a practicing oncologist * treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app * provide consent for the study Exclusion Criteria: Patients-…
The intervention will consist of patients using the MyPatientPal+ application to complete daily patient reported outcome questions (PROs) of: (a) patient quality of life, (b) medication use, and (c) severity of side effects, and their providers who will elect to receive a weekly summary of patient's daily PRO reports electronically (e.g., email) or through the dashboard.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.